Paragon Biosciences Skyline Capital
Northbrook, US · Founded 2018 · Delaware LLC
Founders & leadership
TC
Timothy CunniffManager
PM
Patrick MorrisManager; President, Secretary and Treasurer
Board
JA
Jeffrey AroninManager
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2018
▶$4MraisedAug 2018 · 15 investors · PharmaceuticalsRule 506(b)
▶$4MraisedAug 2018 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Timothy CunniffDirector
- Jeffrey AroninDirector
- Patrick MorrisExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $10K
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Paragon Biosciences Skyline Capital raised?
- Paragon Biosciences Skyline Capital has disclosed $4M raised across 1 round.
- Where is Paragon Biosciences Skyline Capital headquartered?
- Paragon Biosciences Skyline Capital is headquartered in Northbrook, US.